N-Power Medicine

N-Power Medicine (operating via npowermedicine.com) is a premier clinical research and healthcare technology enterprise engineered to accelerate oncology drug development. Founded in 2021 and headquartered in Redwood City, California, the company fundamentally transforms community oncology by making routine care and research one and the same. Moving far beyond traditional, slow clinical trials, N-Power natively unifies prospective external controls, an always-on clinical trial accelerator, and an AI-enabled point-of-care platform into a single, cohesive ecosystem. The platform empowers community oncologists to embed research into their daily workflows without disruption, saving physicians hours per week while engaging diverse patient populations. Under the hood, their sophisticated Kaleido Registry and human-in-the-loop AI infrastructure automatically handle chart reviews and standard-of-care data collection, ensuring rigorous privacy and quality standards like HITRUST and HIPAA compliance. Building a massive hyper-local research network across the US and backed by top-tier investors, N-Power Medicine remains a definitive cornerstone of the modern clinical drug development landscape, bringing cutting-edge trials directly to where 80% of cancer patients receive care.